Position in ZTS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,077
-$696 QoQ
Shares Held
15
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,361
of 1,408 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 20261620 INVESTMENT ADVISORS, INC. holds $895,573 across 9 Drug Manufacturers - Specialty & Generic names. ZTS ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
24,191 | $384,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
356 | $192,891 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
997 | $168,034 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,577 | $53,428 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
407 | $45,152 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
834 | $21,158 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
550 | $17,270 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
615 | $12,410 |
All Filings in ZTS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,077 | 15 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,773 | 15 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,887 | 15 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,194 | 15 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $2,339 | 15 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,469 | 15 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,584 | 22 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,367 | 7 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||